Randomized Control Trial on the Effectiveness of Collagen Cross-linking on Bullous Keratopathy
Conclusions:
CXL reduced corneal thickness in the patients with BK, at least for the initial period. However, there were no improvement in pain, corneal clarity, and vision that were of more clinical relevance to the patients. Its short-term benefit was unlikely to outweigh its potential risk of recurrent epithelial defect.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
More News: Corneal Transplant | Keratoconus | Opthalmology | Pain | Science | Statistics | Study | Transplants